Skip to main content
SpringerLink
Log in

ASO Author Reflections: Pre-transplant Treatments for Patients with Hepatocellular Carcinoma Before Liver Transplantation

  • Aso Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Adam R, Bhangui P, Vibert E, et al. Resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver: does size define the best oncological strategy? Ann Surg. 2012;256(6):883–91.

    Article  Google Scholar 

  2. Ma KW, Cheung TT. When to consider liver transplantation in hepatocellular carcinoma patients? Hepat Oncol. 2017;4(1):15–24.

    Article  Google Scholar 

  3. DiNorcia J, Florman SS, Haydel B, et al. Pathologic response to pretransplant locoregional therapy is predictive of patient outcome after liver transplantation for hepatocellular carcinoma: analysis from the US multicenter HCC transplant consortium. Ann Surg. 2020;271(4):616–24.

    Article  Google Scholar 

  4. Agopian VG, Morshedi MM, McWilliams J, et al. Complete pathologic response to pretransplant locoregional therapy for hepatocellular carcinoma defines cancer cure after liver transplantation: analysis of 501 consecutively treated patients. Ann Surg. 2015;262(3):536–45.

    Article  Google Scholar 

  5. Shimada S, Shamaa T, Ivanics T, et al. Multiple pre-transplant treatments for patients without pathological complete response may worsen post-transplant outcomes in patients with hepatocellular carcinoma. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-12789-2

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Transplant and Hepatobiliary Surgery, Henry Ford Health System, Detroit, MI, USA

    Shingo Shimada MD, PhD, Marwan Abouljoud MD & Shunji Nagai MD, PhD

Authors
  1. Shingo Shimada MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marwan Abouljoud MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shunji Nagai MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shunji Nagai MD, PhD.

Ethics declarations

Disclosure

Shingo Shimada, Marwan Abouljoud, and Shunji Nagai have no conflicts of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shimada, S., Abouljoud, M. & Nagai, S. ASO Author Reflections: Pre-transplant Treatments for Patients with Hepatocellular Carcinoma Before Liver Transplantation. Ann Surg Oncol 30, 1420–1421 (2023). https://doi.org/10.1245/s10434-022-12964-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-12964-5

Search

Navigation